Abnormal Capillary Vasodynamics Contribute to Ictal Neurodegeneration in Epilepsy
Popp, Pamela J. Osborn
Calhoun, Michael E.
Arribas, Juan I.
Schlegel, Alexander A.
Stasi, Leandro L. Di
Rho, Jong M.
Treiman, David M.
Macknik, Stephen L.
AffiliationUniv Arizona, Coll Med
MetadataShow full item record
PublisherNATURE PUBLISHING GROUP
CitationAbnormal Capillary Vasodynamics Contribute to Ictal Neurodegeneration in Epilepsy 2017, 7:43276 Scientific Reports
Rights© The Author(s) 2017. This work is licensed under a Creative Commons Attribution 4.0 International License.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractSeizure-driven brain damage in epilepsy accumulates over time, especially in the hippocampus, which can lead to sclerosis, cognitive decline, and death. Excitotoxicity is the prevalent model to explain ictal neurodegeneration. Current labeling technologies cannot distinguish between excitotoxicity and hypoxia, however, because they share common molecular mechanisms. This leaves open the possibility that undetected ischemic hypoxia, due to ictal blood flow restriction, could contribute to neurodegeneration previously ascribed to excitotoxicity. We tested this possibility with Confocal Laser Endomicroscopy (CLE) and novel stereological analyses in several models of epileptic mice. We found a higher number and magnitude of NG2+ mural-cell mediated capillary constrictions in the hippocampus of epileptic mice than in that of normal mice, in addition to spatial coupling between capillary constrictions and oxidative stressed neurons and neurodegeneration. These results reveal a role for hypoxia driven by capillary blood flow restriction in ictal neurodegeneration.
VersionFinal published version
SponsorsAmerican Epilepsy Society; Arizona Biomedical Research Commission; Research to Prevent Blindness Inc.; National Science Foundation [0726113, 0852636, 1523614]; Barrow Neurological Foundation; Mrs Marian Rochelle award; Mrs Grace Welton award; Dignity Health SEED award; Research Preventing Blindness Foundation; Empire Innovator Scholar (New York State) funds; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0138]; Spanish Ministry of Education; Fundacion Seneca - Agencia de Ciencia y Tecnologia de la Region de Murcia; Fundacion Ibercaja; Fundacion Pedro Barrie de la Maza; MEC-Fulbright Postdoctoral Fellowship program [PS-2010-0667]; NICHD; New York State Empire Innovation Program
- Comparison of heart rate variability parameters during complex partial seizures and psychogenic nonepileptic seizures.
- Authors: Ponnusamy A, Marques JL, Reuber M
- Issue date: 2012 Aug
- Impaired neurovascular coupling to ictal epileptic activity and spreading depolarization in a patient with subarachnoid hemorrhage: possible link to blood-brain barrier dysfunction.
- Authors: Winkler MK, Chassidim Y, Lublinsky S, Revankar GS, Major S, Kang EJ, Oliveira-Ferreira AI, Woitzik J, Sandow N, Scheel M, Friedman A, Dreier JP
- Issue date: 2012 Nov
- Interictal to ictal transition in human temporal lobe epilepsy: insights from a computational model of intracerebral EEG.
- Authors: Wendling F, Hernandez A, Bellanger JJ, Chauvel P, Bartolomei F
- Issue date: 2005 Oct
- Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
- Authors: Levite M
- Issue date: 2014 Aug
- Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures.
- Authors: Penkowa M, Florit S, Giralt M, Quintana A, Molinero A, Carrasco J, Hidalgo J
- Issue date: 2005 Feb 15